These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 36587875)

  • 1. Multi-omics and network pharmacology study reveals the effects of Dengzhan Shengmai capsule against neuroinflammatory injury and thrombosis induced by ischemic stroke.
    Ye J; Huang F; Zeng H; Xu X; Wu G; Tian S; Zhao J; Zhang W
    J Ethnopharmacol; 2023 Apr; 305():116092. PubMed ID: 36587875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA sequencing reveals that VIM and IFITM3 are vital targets of Dengzhan Shengmai capsule to protect against cerebral ischemic injury.
    Cao GZ; Hou JY; Zhou R; Tian LL; Wang ML; Zhang Y; Xu H; Yang HJ; Zhang JJ
    J Ethnopharmacol; 2023 Jul; 311():116439. PubMed ID: 37004745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4,5 caffeoylquinic acid and scutellarin, identified by integrated metabolomics and proteomics approach as the active ingredients of Dengzhan Shengmai, act against chronic cerebral hypoperfusion by regulating glutamatergic and GABAergic synapses.
    Sheng N; Zheng H; Li M; Li M; Wang Z; Peng Y; Yu H; Zhang J
    Pharmacol Res; 2020 Feb; 152():104636. PubMed ID: 31926275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing network pharmacology, molecular docking, and animal models to explore the therapeutic potential of the WenYang FuYuan recipe for cerebral ischemia-reperfusion injury through AGE-RAGE and NF-κB/p38MAPK signaling pathway modulation.
    Zhang D; Qin H; Chen W; Xiang J; Jiang M; Zhang L; Zhou K; Hu Y
    Exp Gerontol; 2024 Jun; 191():112448. PubMed ID: 38697555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Astragalus mongholicus Bunge ameliorating cerebral ischemia-reperfusion injury: Based on network pharmacology analysis and experimental verification.
    Li R; Lou Q; Ji T; Li Y; Yang H; Ma Z; Zhu Y; Qian C; Yang W; Wang Y; Luo S
    J Ethnopharmacol; 2024 Jul; 329():118157. PubMed ID: 38588987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Mailuo Shutong Pills in treatment of ischemic stroke based on network pharmacological analysis and experimental verification].
    Yang YF; Peng SX; Wang KY; Zhu CT; Zhong HS; Che FY
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(23):6466-6475. PubMed ID: 36604893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury.
    Yang T; Chen X; Mei Z; Liu X; Feng Z; Liao J; Deng Y; Ge J
    Drug Des Devel Ther; 2021; 15():3783-3808. PubMed ID: 34522084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiomics and network pharmacological study reveals the neuroprotective efficacy of Fu-Fang-Dan-Zhi tablets against glutamate-induced oxidative cell death.
    Gu Y; Huang P; Cheng T; Yang J; Wu G; Sun Y; Liu A; Li H; Zhao J; Ye J
    Comput Biol Med; 2022 Sep; 148():105873. PubMed ID: 35868043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of Action of Dengzhan Shengmai in Regulating Stroke from an Inflammatory Perspective: A Preliminary Analysis of Network Pharmacology.
    Yan Y; Sun C; Rong X; Han R; Zhu S; Su R; Jin Y; Li L; Liu J
    Evid Based Complement Alternat Med; 2021; 2021():6138854. PubMed ID: 34754318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the underlying mechanism of Buyang Huanwu decoction in ischemic stroke by integrating systems pharmacology-proteomics and in vivo experiments.
    Liao W; Wang P; He Y; Liu Z; Wang L
    Fitoterapia; 2024 Jun; 175():105935. PubMed ID: 38580032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated evidence of Dengzhan Shengmai capsule against ischemic stroke: A systematic review and meta-analysis.
    Liu X; Li Y; Bai N; Yu C; Xiao Y; Li C; Liu Z
    J Ethnopharmacol; 2022 Jan; 283():114675. PubMed ID: 34571078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats.
    Wang M; Liu F; Yao Y; Zhang Q; Lu Z; Zhang R; Liu C; Lin C; Zhu C
    J Ethnopharmacol; 2021 Apr; 270():113816. PubMed ID: 33444723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Sanhua Decoction in the Treatment of Ischemic Stroke Based on Network Pharmacology Methods and Experimental Verification.
    YingHuang ; Gao SS; Gong ZH; Li WJ; Xiao-junGou ; Sun JJ; Sun MJ
    Biomed Res Int; 2022; 2022():7759402. PubMed ID: 35097126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic understanding of the effect of Dengzhan Shengmai capsule on the pharmacokinetics of clopidogrel in rats.
    Chen X; Zhao Z; Chen Y; Gou X; Zhou Z; Zhong G; Cai Y; Huang M; Jin J
    J Ethnopharmacol; 2016 Nov; 192():362-369. PubMed ID: 27459888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound Dan Zhi tablet attenuates experimental ischemic stroke via inhibiting platelet activation and thrombus formation.
    Cheng TF; Zhao J; Wu QL; Zeng HW; Sun YT; Zhang YH; Mi R; Qi XP; Zou JT; Liu AJ; Jin HZ; Zhang WD
    Phytomedicine; 2020 Dec; 79():153330. PubMed ID: 32932202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Network Pharmacology and Experimental Approach to Investigate the Protective Effect of Jin Gu Lian Capsule on Rheumatoid Arthritis by Inhibiting Inflammation via IL-17/NF-κB Pathway.
    Chen T; Li S; Lian D; Hu Q; Hou H; Niu D; Li H; Song L; Gao Y; Chen Y; Hu X; Li J; Ye Z; Peng B; Zhang G
    Drug Des Devel Ther; 2023; 17():3723-3748. PubMed ID: 38107658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational systems pharmacology reveals an antiplatelet and neuroprotective mechanism of Deng-Zhan-Xi-Xin injection in the treatment of ischemic stroke.
    Zhao J; Lv C; Wu Q; Zeng H; Guo X; Yang J; Tian S; Zhang W
    Pharmacol Res; 2019 Sep; 147():104365. PubMed ID: 31348992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems pharmacology, proteomics and in vivo studies identification of mechanisms of cerebral ischemia injury amelioration by Huanglian Jiedu Decoction.
    Shang J; Li Q; Jiang T; Bi L; Lu Y; Jiao J; Song Q; Yan M; Shabuerjiang L; Wang J; Liu X
    J Ethnopharmacol; 2022 Jul; 293():115244. PubMed ID: 35378193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke.
    Cui Q; Zhang YL; Ma YH; Yu HY; Zhao XZ; Zhang LH; Ge SQ; Zhang GW; Qin XD
    J Ethnopharmacol; 2020 Jul; 257():112891. PubMed ID: 32315738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis.
    Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y
    J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.